IRTC
iRhythm Technologies, Inc.NASDAQHealthcare$116.80-1.20%ClosedMarket Cap: $3.77B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
24.67
P/S
5.05
EV/EBITDA
-542.61
DCF Value
$111.33
FCF Yield
0.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
70.6%
Operating Margin
-6.8%
Net Margin
-6.0%
ROE
-38.3%
ROA
-4.4%
ROIC
-5.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $208.9M | 70.9% | $8.8M | $5.6M | $0.17 | — |
| FY 2025 | $747.1M | 70.6% | $-36.8M | $-44.6M | $-1.39 | — |
| Q3 2025 | $192.9M | 71.1% | $-8.4M | $-5.2M | $-0.16 | — |
| Q2 2025 | $186.7M | 71.2% | $-18.7M | $-14.2M | $-0.45 | — |
| Q1 2025 | $158.7M | 68.8% | $-32.6M | $-30.7M | $-0.97 | — |
| Q4 2024 | $164.3M | 70.0% | $-4.1M | $-1.3M | $-0.04 | — |
| FY 2024 | $591.8M | 68.9% | $-115.5M | $-113.3M | $-3.63 | — |
| Q3 2024 | $147.5M | 68.8% | $-50.3M | $-46.2M | $-1.48 | — |
| Q2 2024 | $148.0M | 69.9% | $-23.0M | $-20.1M | $-0.65 | — |
| Q1 2024 | $131.9M | 66.3% | $-38.1M | $-45.7M | $-1.47 | — |
| Q4 2023 | $132.5M | 66.0% | $-39.2M | $-38.7M | $-1.26 | — |
| FY 2023 | $492.7M | 67.3% | $-125.2M | $-123.4M | $-4.04 | — |